Biotech

All Articles

Capricor shares more records for DMD therapy after launching BLA

.Capricor Rehabs is actually taking a success lap for their stage 2 Duchenne muscle dystrophy (DMD) ...

FDA locations Kezar lupus trial in hold following 4 person deaths

.The FDA has actually put Kezar Life Sciences' lupus trial on grip after the biotech flagged 4 fatal...

Phase 3 Academic Stone trial strikes SMA target, sending stockpile 200%

.A stage 3 trial of Scholar Stone's spinal muscular atrophy (SMA) candidate has actually hit its maj...

CAMP 4 is most current to eye IPO, while Upstream point out $182M plan

.RNA biotech CAMP4 Rehabs has marked out prepare for a $67 thousand IPO, along with inflammation-foc...

Galecto gets leukemia medication, loses bone cancer cells resource in pivot

.A year after the failure of an idiopathic pulmonary fibrosis candidate sent out Galecto on a hunt f...

Judo throws down $100M to knock out renal health condition

.Taking the floor covering is actually Judo Biography, a promising biotech armed with $100 thousand ...

AstraZeneca pays out CSPC $100M for preclinical heart problem drug

.AstraZeneca has actually paid off CSPC Pharmaceutical Group $one hundred thousand for a preclinical...

Zephyrm seeks Hong Kong IPO to finance stage 3 tissue treatment tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock market, submission (PDF) for an IPO to st...

Frazier Lifestyle Sciences collects $630M for tiny, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an even further $630 thousand for its own fund focus...

GigaGen gets as much as $135M BARDA bucks to hammer botulism

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its s...